In vivo profile of the human leukocyte microRNA response to endotoxemia

https://doi.org/10.1016/j.bbrc.2008.12.190Get rights and content

Abstract

To gain insight into microRNAs (miRNAs) involved in the regulation of the human innate immune response, we screened for differentially expressed miRNAs in circulating leukocytes in an in vivo model of acute inflammation triggered by Escherichia coli lipopolysaccharide (LPS) infusion.

Leukocyte RNA was isolated from venous blood samples obtained from healthy male volunteers before and 4 h after LPS-infusion. After fluorescence labeling, RNA samples were hybridized to microarrays containing capture probes for measuring the abundance of more than 600 human miRNAs. Target genes were predicted for differentially expressed miRNAs and then compared to changes in genome-wide expression levels, which had been established in a previous study.

Data analysis revealed that five miRNAs consistently responded to LPS-infusion, four of which were down-regulated (miR-146b, miR-150, miR-342, and let-7g) and one was up-regulated (miR-143). The miR-150 and mir-342 response was confirmed by real-time PCR. By correlating to measured LPS-induced changes of the leukocyte transcriptome, we next searched for predicted target genes, whose stability might be under (co-) control by these miRNAs. We found that the rapid transcriptional activation during acute inflammation of select genes, such as the gene encoding interleukin-1 receptor-associated kinase 2 (IRAK2) might be facilitated by decreased levels of LPS-responsive miRNAs. The increased level of miR-143 might be associated with the pronounced down-regulation of the B-cell CLL/lymphoma 2 (BCL2) gene expression during LPS endotoxemia, and could further be involved in the translational silencing of several other predicted inflammation-related target genes.

This is the first in vivo study to demonstrate relative abundance of miRNA levels in peripheral blood leukocytes during acute LPS-induced inflammation. The miRNAs and their potential target genes identified herein contribute to the understanding of the complex transcriptional program of innate immunity initiated by pathogens.

Section snippets

Materials and methods

Subjects and study design. The study population included three healthy, normal weight, drug free, male volunteers. Health was defined as the absence of a detectable disease as defined by normal results from history, physical examination, ECG, blood pressure, clinical chemistry, complete blood count, hepatitis virus serology, and HIV test. The study was approved by the Ethics Committee of the Medical University of Vienna, performed in accordance with the Declaration of Helsinki, the Austrian

LPS-induced differential miRNA levels

In the first step, we analyzed the microarray data by comparing RNA samples obtained from blood before (baseline) and 4 h after LPS-infusion. When employing paired t-test based statistics to discover differentially expressed miRNAs, we found seven miRNAs with different abundance after LPS-infusion compared with baseline (Fig. 1). Of these, four were detected at lower level after LPS (miR-146b, miR-150, miR-342, and let-7g), while three miRNAs (miR-143, and two proprietary miRNAs that are not in

Conclusions

In this study, we screened for changes induced by LPS to the in vivo miRNA profile of human circulating leukocytes and found that a relatively small number of miRNAs are subject to differential expression. At least for select targets, we were able to correlate miRNA changes to differential expression during LPS-induced inflammation. While it is not possible to draw definite conclusions as suggested targets of LPS-responsive miRNAs have not been validated experimentally, the predicted targets

References (33)

  • B. Beutler et al.

    Innate immune sensing and its roots: the story of endotoxin

    Nat Rev Immunol

    (2003)
  • S.E. Calvano et al.

    A network-based analysis of systemic inflammation in humans

    Nature

    (2005)
  • U. Prabhakar et al.

    Correlation of protein and gene expression profiles of inflammatory proteins after endotoxin challenge in human subjects

    DNA Cell Biol

    (2005)
  • W.M. Schmidt et al.

    In-vivo effects of simvastatin and rosuvastatin on global gene expression in peripheral blood leucocytes in a human inflammation model

    Pharmacogenet Genomics

    (2008)
  • S. Talwar et al.

    Gene expression profiles of peripheral blood leukocytes after endotoxin challenge in humans

    Physiol Genomics

    (2006)
  • M.P. Gantier et al.

    Fine-tuning of the innate immune response by microRNAs

    Immunol Cell Biol

    (2007)
  • Cited by (106)

    • Trichoderma stromaticum spores induce autophagy and downregulate inflammatory mediators in human peripheral blood-derived macrophages

      2022, Current Research in Microbial Sciences
      Citation Excerpt :

      MiR-146 and miR-155 are known by their ability to differentially contribute to endotoxin-inflammatory responses (Das Gupta et al., 2014). The first maintains a sub-inflammatory immune response or decrease the human leukocyte activities, while the second has pro-inflammatory characteristics (Nahid et al., 2009; Schmidt et al., 2009). Since miR-155 has an inflammatory effect while miR-146 has an anti-inflammatory effect (Testa et al., 2017; Zhao et al., 2016).

    • MiR-150 attenuates LPS-induced acute lung injury via targeting AKT3

      2019, International Immunopharmacology
      Citation Excerpt :

      Our results inferred that miR-150 inhibited JNK and NF-κB pathways probably through targeting AKT3 pathway. In recent years, miR-150 has been identified to be implicated in host response to LPS [9]. Here, we firstly demonstrated that miR-150 was down-regulated, and inversely correlated with the disease severity and 28-day survival in patients with ARDS.

    • Angiopoietin-like 8 (ANGPTL8) expression is regulated by miR-143-3p in human hepatocytes

      2019, Gene
      Citation Excerpt :

      Previous studies have shown that miR-143 levels are higher in vascular smooth muscles cells (SMCs) from diabetic individuals compared to healthy controls, but in vitro treatment of SMCs with high glucose or insulin produced no significant effect on miRNA expression (Riches et al., 2014). Similarly, miR-143-3p upregulation in the presence of LPS in the current study is consistent with findings of increased circulating leukocyte levels of the miRNA in healthy male volunteers following LPS infusion (Schmidt et al., 2009). In that study, miR-143 levels were also associated with downregulation of pro-inflammatory genes.

    View all citing articles on Scopus
    View full text